Pemphigoid Antibody Panel
Synonyms |
|
||||||||||||
Cerner Name |
|||||||||||||
Clinical Info |
Use to assess and monitor pemphigoid, pemphigoid variants, and linear IgA disease and to discriminate among the immunobullous diseases with epithelial basement membrane zone antibodies. |
||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||
Specimen Types |
Blood |
||||||||||||
Container |
Gold Top Tube or Red Top Tube |
||||||||||||
Collection Instructions |
Container/Tube: Gold Top Tube or Red Top Tube |
||||||||||||
Specimen Volume |
2 mL serum ( 0.5 mL min) |
||||||||||||
Transport Instructions |
Refrigerated |
||||||||||||
Specimen Stability |
7 Days Room Temperature |
||||||||||||
Methodology |
Semi-Quantitative Indirect Immunofluorescence (IIF)/Semi-Quantitative Enzyme-Linked Immunosorbent Assay (ELISA) |
||||||||||||
Days Performed |
TAT: 4 - 10 Days |
||||||||||||
Performing Laboratory |
ARUP Laboratories |
||||||||||||
CPT |
88346 |
||||||||||||
PDM |
245350 |
||||||||||||
Only Orderable at Locations: |
Orderable Everywhere |
||||||||||||
Results |
|
||||||||||||
Result InterpretationSee Report Bullous pemphigoid and other pemphigoid variants, epidermolysis bullosa acquisita (EBA), linear IgA disease, and dermatitis herpetiformis may present with similar clinical findings including blistering, erosions, pruritus, and urticaria, which affect skin and mucous membranes.
|
|||||||||||||
Forms |
|